|
POLDIP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.77236045021345E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13242748511766E-14 |
| Normal-vs-Stage2 |
1.97294999999542E-05 |
| Normal-vs-Stage3 |
3.17389999837658E-08 |
| Normal-vs-Stage4 |
1.34660005368659E-09 |
| Stage1-vs-Stage2 |
5.220800E-01 |
| Stage1-vs-Stage3 |
8.643400E-01 |
| Stage1-vs-Stage4 |
3.175200E-01 |
| Stage2-vs-Stage3 |
4.092200E-01 |
| Stage2-vs-Stage4 |
8.856300E-02 |
| Stage3-vs-Stage4 |
3.029000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.32587340685131E-15 |
| Normal-vs-AfricanAmerican |
4.95909979747466E-11 |
| Normal-vs-Asian |
8.43339997835812E-09 |
| Caucasian-vs-AfricanAmerican |
9.440000E-01 |
| Caucasian-vs-Asian |
1.285230E-01 |
| AfricanAmerican-vs-Asian |
9.912200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62536650805123E-12 |
| Normal-vs-Female |
4.54919999448578E-08 |
| Male-vs-Female |
1.943440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.14549999777836E-09 |
| Normal-vs-Extreme_Weight |
2.20146123552922E-12 |
| Normal-vs-Obese |
3.80789999532283E-08 |
| Normal-vs-Extreme_Obese |
4.00260000033015E-07 |
| Normal_Weight-vs-Extreme_Weight |
9.404200E-01 |
| Normal_Weight-vs-Obese |
1.546020E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.393600E-01 |
| Extreme_Weight-vs-Obese |
1.154030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.722800E-01 |
| Obese-vs-Extreme_Obese |
4.170400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.797700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.72309977187047E-10 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.10819999999501E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.635600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.790220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.683610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.454330E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.472190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.766800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.74638081773537E-13 |
| Normal-VS-Type2 PRCC |
1.62481139653892E-12 |
| Normal-VS-KIRP CIMP |
3.743100E-03 |
| Normal-VS-Unclassified PRCC |
8.65720000020609E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.811700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.167200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.680200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.151800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.644200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.822400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.72617475868719E-12 |
| Normal-vs-N1 |
9.98920000000458E-05 |
| Normal-vs-N2 |
2.159800E-04 |
| N0-vs-N1 |
2.638800E-01 |
| N0-vs-N2 |
7.371200E-01 |
| N1-vs-N2 |
8.382600E-01 |
|
|
